CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-025-60456-3
Download full text from publisher
References listed on IDEAS
- Sean A. Yamada-Hunter & Johanna Theruvath & Brianna J. McIntosh & Katherine A. Freitas & Frank Lin & Molly T. Radosevich & Amaury Leruste & Shaurya Dhingra & Naiara Martinez-Velez & Peng Xu & Jing Hua, 2024. "Engineered CD47 protects T cells for enhanced antitumour immunity," Nature, Nature, vol. 630(8016), pages 457-465, June.
- Jun Chen & Ming-Chao Zhong & Huaijian Guo & Dominique Davidson & Sabrin Mishel & Yan Lu & Inmoo Rhee & Luis-Alberto Pérez-Quintero & Shaohua Zhang & Mario-Ernesto Cruz-Munoz & Ning Wu & Donald C. Vinh, 2017. "SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin," Nature, Nature, vol. 544(7651), pages 493-497, April.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Shravan Leonard-Murali & Chetana Bhaskarla & Ghanshyam S. Yadav & Sudeep K. Maurya & Chenna R. Galiveti & Joshua A. Tobin & Rachel J. Kann & Eishan Ashwat & Patrick S. Murphy & Anish B. Chakka & Visha, 2024. "Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Pablo Domizi & Jolanda Sarno & Astraea Jager & Milton Merchant & Kaithlen Zen B. Pacheco & Sean A. Yamada-Hunter & Maria Caterina Rotiroti & Yuxuan Liu & Reema Baskar & Warren D. Reynolds & Brian J. S, 2025. "IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
- Awatef Allouch & Laurent Voisin & Yanyan Zhang & Syed Qasim Raza & Yann Lecluse & Julien Calvo & Dorothée Selimoglu-Buet & Stéphane Botton & Fawzia Louache & Françoise Pflumio & Eric Solary & Jean-Luc, 2022. "CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60456-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.